Comparative-Effectiveness Research in Molecular Imaging

Tuesday, June 7 | 2:30 PM - 4:00 PM
Room 006CD

Objectives
Upon completion of this activity, the participant will be able to:
1. Assess and interpret comparative-effectiveness research (CER) studies in terms of type of study design, research perspective, comparison groups, sub-population studied, primary findings, limitations and implications.
2. Develop CER study questions in molecular imaging modalities and develop hypotheses for and approaches to CER.
3. Discuss completely the broad implications of CER in molecular imaging and in medicine.

Speakers are:
Michael M. Graham, PhD, MD, University of Iowa Carver College of Medicine in Iowa City, Iowa;
Brian W. Bresnahan, PhD, Harborview Medical Center in Seattle; and
Daniel H. Silverman, MD, PhD, University of California, Los Angeles.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.